Who is sponsoring NCT06228534?

NCT06228534 is sponsored by Luis Alberto Chauca Bajaña.

What drugs are being tested in NCT06228534?

Interventions in NCT06228534: Root coverage with tunneling technique.

What condition does NCT06228534 study?

NCT06228534 studies Gingival Recession, Localized, Gingival Recession.

Is NCT06228534 still recruiting?

NCT06228534 is currently completed. Last updated 2 July 2025.

Last reviewed 2025-07-02 · How we verify

NCT06228534

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Root Coverage With Tunneling Technique With Connective Tissue Versus Coronal Advancement Flap Technique.

Completed EARLY_PHASE1 Last updated 2 July 2025

What this trial tests

EARLY_PHASE1 trial testing Root coverage with tunneling technique in Gingival Recession, Localized in 20 participants. Completed in 20 June 2025.

Timeline

15 January 2024

Primary endpoint
15 December 2024

20 June 2025

Quick facts

Lead sponsor	Luis Alberto Chauca Bajaña
Phase	EARLY_PHASE1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	quadruple
Primary purpose	treatment
Enrollment	20
Start date	15 January 2024
Primary completion	15 December 2024
Estimated completion	20 June 2025
Sites	1 location across Ecuador

Drugs / interventions tested

Root coverage with tunneling technique

Conditions studied

Gingival Recession, Localized — all drugs for Gingival Recession, Localized →
Gingival Recession — all drugs for Gingival Recession →

Sponsor

Luis Alberto Chauca Bajaña

Who can join

Adults 20 to 50, any sex, with Gingival Recession, Localized or Gingival Recession. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized triple-blind clinical trial. This comparative clinical study investigates the efficacy of root coverage using two periodontal techniques: the tunneling technique and the coronal advancement technique. The objective is to evaluate and compare the clinical, esthetic and patient perception outcomes after undergoing each procedure. Participants with specific gingival recessions will be included, and follow-up will be performed to measure root coverage, keratinized tissue gain and other relevant parameters. In addition, a detailed analysis of the morbidity associated with each technique will be performed. This study aims to provide valuable information to guide oral health professionals in choosing the most appropriate technique for the treatment of gingival recessions.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparative Effectiveness of Tunneling vs. Coronally Advanced Flap Techniques for Root Coverage: A 6-12-Month Randomized Clinical Trial.
Chauca-Bajaña L, Vásquez González PS, Alban Guijarro MJ, Guim Martínez CA, et al · · 2025 · cited 1× · PMID 40868339 · DOI 10.3390/bioengineering12080824

Verify or expand the search:

Other recruiting trials for Gingival Recession, Localized

Currently open trials in the same condition.

NCT07430670 — Theravex Oral and Theravex Tissue Care Plus in the Healing Process of Mucogingival Surgery · NA · recruiting
NCT07409571 — Palatal Wound Healing After Free Gingival Graft Surgery · NA · recruiting
NCT07158541 — Comparing TCAF and MTUN With Soft Tissue Grafting for Treating Single Recessions in the Premandible · NA · recruiting
NCT07158528 — Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Maxilla. · NA · recruiting
NCT06940050 — Comparing CAF and TCAF With Soft Tissue Grafting for Treating Multiple Recessions in the Premandibula. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06228534 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Luis Alberto Chauca Bajaña
Last refreshed: 2 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06228534.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing